Roundhill GLP-1 & Weight Loss ETF Rating $25.88 +0.28 (+1.09%) As of 02/21/2025 03:49 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartDividendHeadlinesHoldingsOwnershipRatingsShort InterestTrends Roundhill GLP-1 & Weight Loss ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.OZEM Aggregate RatingModerate Buy 2.86Holdings in OZEM have an aggregate rating of Moderate Buy based on 223 analyst ratings issued in the past year covering 17 companies (67.5% of the portfolio).OZEM Aggregate Price Target$25.88High Prediction$25.88Average Prediction$25.88Low Prediction$25.88Holdings in OZEM have an aggregate price target of $25.88 and a range of $25.88 to $25.88 covering 17 companies (67.5% of the portfolio).OZEM Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy8 Buy rating(s)Moderate Buy8 Moderate Buy rating(s)Hold1 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Roundhill GLP-1 & Weight Loss ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 17 OZEM Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings17.41%LLYEli Lilly and Company$874.12+0.1%4.8446 of 5 stars2.85$1,000.28 14.4%20Positive News14.84%NVONovo Nordisk A/S$88.07+5.2%4.4853 of 5 stars2.88$145.25 64.9%8Gap Up4.71%AZNAstraZeneca$74.20-0.5%2.6822 of 5 stars3.10$89.75 21.0%10Options Volume4.24%AMGNAmgen$303.01+1.7%4.4634 of 5 stars2.46$314.09 3.7%24Insider TradePositive News3.52%PFEPfizer$26.32+1.6%4.9993 of 5 stars2.50$31.92 21.3%16Options VolumePositive News2.93%GPCRStructure Therapeutics$23.70+1.3%2.4982 of 5 stars3.00$81.29 243.1%82.66%ALTAltimmune$6.43-3.0%2.6022 of 5 stars3.00$20.83 224.0%8Short Interest ↓News Coverage2.62%VKTXViking Therapeutics$34.07+7.7%4.3749 of 5 stars3.00$97.29 185.5%15High Trading Volume2.56%REGNRegeneron Pharmaceuticals$700.33+0.6%4.7635 of 5 stars2.76$973.13 39.0%25Dividend Announcement2.17%GILDGilead Sciences$109.95-0.1%4.7853 of 5 stars2.72$102.08 -7.2%29Analyst UpgradeInsider TradeOptions VolumeAnalyst RevisionPositive News1.86%SRRKScholar Rock$37.70-3.7%3.0476 of 5 stars3.14$40.43 7.2%7Insider TradeNews Coverage1.79%RYTMRhythm Pharmaceuticals$56.07-2.9%4.0942 of 5 stars2.91$68.09 21.4%11Analyst ForecastInsider TradeNews Coverage1.61%TERNTerns Pharmaceuticals$4.01-2.9%4.3948 of 5 stars2.80$18.30 356.4%51.53%CORTCorcept Therapeutics$63.54-2.4%4.7297 of 5 stars3.00$88.25 38.9%5Upcoming Earnings1.52%BHVNBiohaven$36.90-7.2%3.3961 of 5 stars3.07$63.15 71.1%15Short Interest ↓Positive News1.38%OPKOPKO Health$1.68+0.6%4.0086 of 5 stars3.00$2.75 63.7%30.17%KROSKeros Therapeutics$11.01-0.2%3.4346 of 5 stars2.57$52.56 377.6%14 This page (NASDAQ:OZEM) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersThe Real Hillbilly ElegyThe mountains of Appalachia are incredible to behold. Spanning thousands of miles across Alabama, Kentucky...Porter & Company | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | Sponsored$5,000 DOGE check?Elon Musk's DOGE agenda just took a very surprising turn... Earlier this week, reports emerged that a porti...Altimetry | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | Sponsored2025 AI Blueprint features Nvidia’s march to $5 trillionNvidia is now one of the most valuable companies in the world. It currently ranks second, just behind Apple...Weiss Ratings | SponsoredCollect $7k per month from Tesla’s SECRET dividendThere's a little-known secret about Tesla that even seasoned investors don't know. Despite not paying a tra...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Roundhill GLP-1 & Weight Loss ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Roundhill GLP-1 & Weight Loss ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
